Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

7.1%

1 terminated/withdrawn out of 14 trials

Success Rate

92.3%

+5.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 12 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
8(100.0%)
8Total
N/A(8)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (14)

Showing 14 of 14 trials
NCT02825134Not ApplicableActive Not Recruiting

Comparison of TAVR With SAVR in Younger Low Surgical Risk Patients With Severe Aortic Stenosis

Role: collaborator

NCT03143673Not ApplicableCompleted

ACURATE™ Transapical Aortic Bioprosthesis for Implantation in Patients With Severe Aortic Stenosis (2010-01)

Role: lead

NCT03752996Not ApplicableCompleted

ACURATE TF™ Transfemoral Aortic Bioprosthesis for Implantation in Patients With Severe Aortic Stenosis (2011-03)

Role: lead

NCT02950428Not ApplicableCompleted

ACURATE Neo™ TA Delivery System in Patient With Severe Aortic Stenosis

Role: lead

NCT02909556Not ApplicableCompleted

ACURATE Neo™ AS Aortic Bioprosthesis for Implantation Using the ACURATE neoTM AS TF Transfemoral Delivery System in Patients With Severe Aortic Stenosis

Role: lead

NCT03454360Terminated

CHANGE Neo™ TA Registry With ACURATE Neo™ Aortic Bioprosthesis and ACURATE Neo™ TA Transapical Delivery System

Role: lead

NCT03192813Completed

Safety and Efficacy Comparison Of Two TAVI Systems in a Prospective Randomized Evaluation II

Role: collaborator

NCT02986737Not ApplicableCompleted

ACURATE Neo™ Aortic Bioprosthesis for Implantation Using the ACURATE TA™ LP Transapical Delivery System in Patients With Severe Aortic Stenosis

Role: lead

NCT02987894Completed

PRospective Observation of Aortic reGuRgitation aftEr TAVI and progreSS Over Time: PROGRESS PVL Registry

Role: lead

NCT03003650Not ApplicableCompleted

ACURATE TF™ Transfemoral Aortic Bioprosthesis for Implantation in Patients With Severe Aortic Stenosis:CE-approval Cohort

Role: lead

NCT03567278Not ApplicableCompleted

Feasibility Trial on ACURATE™ Transapical Implantation in Patients With Severe Symptomatic Aortic Stenosis (2009-01)

Role: lead

NCT02663375Completed

ACURATE TA™ Valve Implantation Registry: SAVI 2

Role: lead

NCT02306226Completed

Symetis ACURATE Neo™ Valve Implantation SAVI TF Registry

Role: lead

NCT03143686Completed

ACURATE TA™ Valve Implantation: SAVI Registry (Surveillance Plan #2011-02) (TA-SAVI)

Role: lead

All 14 trials loaded